312 related articles for article (PubMed ID: 25367917)
21. Temporal fluctuation of multidrug resistant salmonella typhi haplotypes in the mekong river delta region of Vietnam.
Holt KE; Dolecek C; Chau TT; Duy PT; La TT; Hoang NV; Nga TV; Campbell JI; Manh BH; Vinh Chau NV; Hien TT; Farrar J; Dougan G; Baker S
PLoS Negl Trop Dis; 2011 Jan; 5(1):e929. PubMed ID: 21245916
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
[TBL] [Abstract][Full Text] [Related]
23. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia.
Kariuki S; Revathi G; Kiiru J; Mengo DM; Mwituria J; Muyodi J; Munyalo A; Teo YY; Holt KE; Kingsley RA; Dougan G
J Clin Microbiol; 2010 Jun; 48(6):2171-6. PubMed ID: 20392916
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria.
Akinyemi KO; Smith SI; Oyefolu AO; Coker AO
Public Health; 2005 Apr; 119(4):321-7. PubMed ID: 15733694
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of gentamicin and amikacin against Salmonella enterica serovar Typhi: a search for a treatment regimen for typhoid fever.
Mandal S; Mandal MD; Pal NK
East Mediterr Health J; 2009; 15(2):264-8. PubMed ID: 19554971
[TBL] [Abstract][Full Text] [Related]
26. Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon.
Nkemngu NJ; Asonganyi ED; Njunda AL
BMC Infect Dis; 2005 Jun; 5():49. PubMed ID: 15969764
[TBL] [Abstract][Full Text] [Related]
27. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006.
Mengo DM; Kariuki S; Muigai A; Revathi G
J Infect Dev Ctries; 2010 Jun; 4(6):393-6. PubMed ID: 20601792
[TBL] [Abstract][Full Text] [Related]
28. Clinical profile, antibiotic susceptibility pattern of bacterial isolates and factors associated with complications in culture-proven typhoid patients admitted to an urban hospital in Bangladesh.
Khatun H; Islam SB; Naila NN; Islam SA; Nahar B; Alam NH; Ahmed T
Trop Med Int Health; 2018 Apr; 23(4):359-366. PubMed ID: 29432657
[TBL] [Abstract][Full Text] [Related]
29. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh.
Asna SM; Haq JA; Rahman MM
Jpn J Infect Dis; 2003 Feb; 56(1):32-3. PubMed ID: 12711825
[No Abstract] [Full Text] [Related]
30. Emergence of multidrug-resistant Salmonella enterica serovar typhi in Korea.
Lee K; Yong D; Yum JH; Lim YS; Kim HS; Lee BK; Chong Y
Antimicrob Agents Chemother; 2004 Nov; 48(11):4130-5. PubMed ID: 15504831
[TBL] [Abstract][Full Text] [Related]
31. A case report and review of the literature: ciprofloxacin resistant Salmonella enterica serovar Typhi in India.
Harish BN; Menezes GA; Sarangapani K; Parija SC
J Infect Dev Ctries; 2008 Aug; 2(4):324-7. PubMed ID: 19741296
[TBL] [Abstract][Full Text] [Related]
32. Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes.
Dimitrov T; Dashti AA; Albaksami O; Udo EE; Jadaon MM; Albert MJ
J Clin Microbiol; 2009 Jan; 47(1):208-11. PubMed ID: 18971360
[TBL] [Abstract][Full Text] [Related]
33. Multidrug-resistant Salmonella enterica serotype Typhi, Gulf of Guinea Region, Africa.
Baltazar M; Ngandjio A; Holt KE; Lepillet E; Pardos de la Gandara M; Collard JM; Bercion R; Nzouankeu A; Le Hello S; Dougan G; Fonkoua MC; Weill FX
Emerg Infect Dis; 2015 Apr; 21(4):655-9. PubMed ID: 25811307
[TBL] [Abstract][Full Text] [Related]
34. In vivo development of amoxicillin and ceftriaxone resistance in Salmonella enterica serovar Typhi.
Tan GSE; Octavia S; Teo JWP; Ang MLT; La MV; Lin RTP; Choudhury S; Ang BSP
Clin Microbiol Infect; 2019 Aug; 25(8):1045-1047. PubMed ID: 30914348
[No Abstract] [Full Text] [Related]
35. Multidrug-resistant typhoid fever outbreak in travelers returning from Bangladesh.
Kato Y; Fukayama M; Adachi T; Imamura A; Tsunoda T; Takayama N; Negishi M; Ohnishi K; Sagara H
Emerg Infect Dis; 2007 Dec; 13(12):1954-5. PubMed ID: 18258058
[No Abstract] [Full Text] [Related]
36. A Race against Time: Reduced Azithromycin Susceptibility in
Iqbal J; Dehraj IF; Carey ME; Dyson ZA; Garrett D; Seidman JC; Kabir F; Saha S; Baker S; Qamar FN
mSphere; 2020 Jul; 5(4):. PubMed ID: 32699118
[TBL] [Abstract][Full Text] [Related]
37. Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever.
Koirala KD; Thanh DP; Thapa SD; Arjyal A; Karkey A; Dongol S; Shrestha UM; Farrar JJ; Basnyat B; Baker S
Antimicrob Agents Chemother; 2012 May; 56(5):2761-2. PubMed ID: 22371897
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern Nepal.
Khanal B; Sharma SK; Bhattacharya SK; Bhattarai NR; Deb M; Kanungo R
J Health Popul Nutr; 2007 Mar; 25(1):82-7. PubMed ID: 17615907
[TBL] [Abstract][Full Text] [Related]
39. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
[TBL] [Abstract][Full Text] [Related]
40. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
